Trevox 500 mg/100 ml IV Infusion
Indication:
Acute maxillary sinusitis, Acute bacterial exacerbation of Chronic bronchitis, Community-acquired pneumonia, Nosocomial Pneumonia, Complicated urinary tract infections, Uncomplicated UTI, Acute pyelonephritis, Chronic bacterial prostatitis, Uncomplicated & complicated skin and soft tissue infections including abscesses, cellulitis, furuncles, impetigo, pyoderma, wound infections.
Inhalation anthrax (post-exposure): To prevent the development of inhalational anthrax following exposure to Bacillus anthracis.
Dosage & Administration:
Acute sinusitis, 500 mg once daily for 10-14 days, Exacerbation of chronic bronchitis, 250-500 mg once daily for 7 days, Community-acquired pneumonia, 500 mg once daily for 7-14 days, Community-acquired pneumonia, 750 mg once daily for 5 days, Nosocomial Pneumonia, 750 mg once daily for 7-14 days, Complicated urinary-tract infections and acute pyelonephritis, 250 mg daily for 7-10 days, Uncomplicated UTI, 250 mg once daily for 3 days, Acute pyelonephritis, 250 mg once daily for 10 days, Chronic bacterial prostatitis, 500 mg once daily for 28 days, Uncomplicated skin and soft-tissue infections, 500 mg once daily for 7-10 days, Complicated skin and soft-tissue infections, 750 mg once daily for 7-14 days.
Inhalation anthrax (post-exposure): Adult-500 mg once daily for 60 days.
Preparation:
Trevox® 500 tablet: Box contains 3 x 10 tablets in blister strip.
Trevox® 750 tablet: Box contains 2 x 10 tablets in blister strip.
